Statistical Method for Assessing the Cost-effectiveness of the Property Insurance Program

The property insurance program developed by the insured determines the main requirements to the conditions, features of the conclusion, execution and termination of the concluded property insurance contracts. When it is implemented for a number of years, when there is a periodic renewal of insurance contracts on standard conditions, the insured has the need to assess the economic effectiveness of such insurance protection, preferably using quantitative indicators. Existing methods of estimating the cost-effectiveness of property insurance programs do not sufficiently take into account the stochastic nature of the insurance process and, in particular, that the resulting losses are subject to extreme type distribution laws studied within the framework of the asymptotic theory of extreme values probabilities. Therefore, for example, it is difficult to adequately assess the economic effectiveness of the property insurance program in a rather frequent situation where the total costs of the insured for paying insurance premiums exceed the total insurance compensation. The proposed statistical method of estimating the economic effectiveness of the property insurance program is based on extreme type distribution functions determined by statistical data, characterizing the claimed losses and insurance compensation paid. The cost effectiveness assessment is carried out using the cost-effectiveness indicator of the property insurance program, which is calculated according to two parameters: the expected share of insurance payments (insurance indemnities) and the premium efficiency coefficient. The expected share of insurance payments is determined by the ratio of mathematical expectations of distribution functions, which characterize the claimed losses and insurance compensation paid. The premium efficiency ratio is the ratio of the gross premium total for the property insurance program, calculated using the function of distributing the claimed losses, and the total amount of premiums paid for the entire period of the property insurance program. Adding up the values of the expected share of insurance payments (insurance indemnities) and the premium efficiency factor taking into account their weights, the value of the economic efficiency indicator of the property insurance program is obtained. The formation of a conclusion on the economic effectiveness of the property insurance program is carried out on the basis of the value of the economic efficiency indicator of the property insurance program according to the proposed scale.

Download Full-text

ECONOMIC EFFECTIVENESS OF CULTIVATION OF PLANTING MATERIAL OF SCOTS PINE (PINUS SYLVESTRIS L.) IN PRIMORSKY REGION

EurasianUnionScientists ◽

10.31618/esu.2413-9335.2020.3.72.629 ◽

2020 ◽

Vol 3 (3(72)) ◽

pp. 54-65

Author(s):

V.Yu. Ostroshenko ◽

R.Yu. Akimov ◽

L.Yu. Ostroshenko

Keyword(s):

Cost Effectiveness ◽

Pinus Sylvestris ◽

Scots Pine ◽

Cost Effectiveness Analysis ◽

Economic Effectiveness ◽

Growth Stimulator ◽

Planting Material ◽

Effectiveness Analysis ◽

The Cost

Cost-effectiveness analysis of cultivation of planting material of Scots pine (Pinus sylvestris L.) with the application of the growth stimulator Crezacin in the nursery of Primorsky region is presented. The cost is 741,02 rub./seedling.

Download Full-text

Cost-effectiveness of measures against rabies

Veterinariya, Zootekhniya i Biotekhnologiya ◽

10.36871/vet.zoo.bio.202012011 ◽

2020 ◽

Vol 1 (12) ◽

pp. 78-83

Author(s):

K. M. Abramov ◽

◽

O. V. Liseykina ◽

I. K. Abramova ◽

◽

...

Keyword(s):

Cost Effectiveness ◽

Russian Federation ◽

Economic Effectiveness ◽

Moscow Region ◽

The Russian Federation ◽

The Cost ◽

Rabies Vaccination

The article presents material on current problems of rabies vaccination: the epizootic situation of rabies in the Russian Federation is considered, the analysis of the dynamics of the number of cases of animal rabies, the population's appeal for anti-rabies care is given. Based on data on preventive rabies vaccination in the Moscow region and the cost of such measures, the economic effectiveness of anti-rabies measures is evaluated.

Download Full-text

The use of mathematical model approach to select direct oral anticoagulants in patients with atrial fibrillation

European Heart Journal ◽

10.1093/ehjci/ehaa946.3374 ◽

2020 ◽

Vol 41 (Supplement_2) ◽

Author(s):

S.V Malchikova ◽

N.S Maksimchuk-Kolobova ◽

M.V Kazakovtseva

Keyword(s):

Atrial Fibrillation ◽

Mathematical Model ◽

Cost Effectiveness ◽

Oral Anticoagulants ◽

Direct Oral Anticoagulants ◽

Economic Effect ◽

Economic Effectiveness ◽

Stroke Treatment ◽

Life Years ◽

The Cost

Abstract Purpose To evaluate the clinical and economic effectiveness of direct oral anticoagulants (DOAC) - dabigatran/D, rivaroxaban/R, apixaban/A compared with warfarin/W in the treatment of atrial fibrillation (AF). Methods The mathematical model (MM) was used (decision-tree building- DTB) to assess the clinical and economic effectiveness of the DOAC use in comparison with W in the AF treatment. MM was based on the results of basic clinical trials on the use of D (RE-LY); R (ROCKET) and A (ARISTOTLE). MM was carried out on a time horizon of 5 years from the perspective of the healthcare system (HS). The method of cost-effectiveness analysis CER. CER = DC/Ef, CER is the cost-effectiveness balance of the alternative, DC is direct costs, Ef is the number of adjusted life years (ALY) and adjusted life years without complications (ALYC). Budget Impact Analysis. BIA = S (1) − S (2), BIA is the result of the analysis of “impact on the budget”, in monetary terms; S (l) – the total economic effect of the use of one drug, in monetary terms; S (2) – the total economic effect of the use of another drug, in monetary terms. Analysis of “lose opportunities”. MOA = ΔS/Costmin, MOA is the result of the analysis of “lose opportunities”, ΔS is the difference in the total economic effects of the two compared drugs, Costmin is the cost of using the lowest cost drugs. Results The MM showed that as a result of pair-wise comparison the DOAC and W, the greatest DC were in group of treatment with the W. The total costs when using D were 10.3% less and amounted to 4129711 against 4605164 rub. per 100 patients. The cost of using R is 5.2% less (4887744 against 5156589); using A by 10.9% (3946528 against 4433820). The greatest difference was due to the different costs of adverse drug reaction treatment (30–38% in the cost structure). In the D group, this cost component was less than the W -by 22.0%, in the R – by 10.9%, in the A – by 36.8%. Costs associated with ischemic stroke treatment were less then 28.1% in the D group. The strategy of using DOAK compared with W allows to provide a greater number of ALY and ALYC – 4, 34 and 4.3 when comparing D and W, 4.3 and 4.25 when R and W; and 4.25 and 4.2 – A and W. ALYC respectively – 3.92 and 3.79; 3.51 and 3.6; 3.9 and 3.74. The cost of ALY is 9516.65 against 10706.45 rub; 11,374.34/12123.81; 9,295.19/10547.31. The cost of ALYC respectively: 10,534.98 against 12150.83 rub.; 13,925.20/14733.11 and 10119.3/11855.13. The use of DOAK allows to save significant public funds, and the savings saved allow to treat the patients in addition by modern drugs. Savings up to 12% in 5 years, while up to 33 patients out of 1000 can be treated additionally. Conclusion DC resulting from the prevention of thromboembolic complications when using DOAC in comparison with W can be reduced by 28.1%, hemorrhagic complications by 36.8%. DOAC can save a greater number of ALY and ALYC at a lower cost. Funding Acknowledgement Type of funding source: None

Download Full-text